Sarcoidosis: an update on current pharmacotherapy options and future directions

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study

(2016) Dae Hyun Yoo et al.   ANNALS OF THE RHEUMATIC DISEASES

Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis

(2016) Li Li et al.   EUROPEAN RESPIRATORY JOURNAL

Biologic therapies in the treatment of sarcoidosis

(2016) Lesley Ann Saketkoo et al.   Expert Review of Clinical Immunology

Consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis

(2016) David H Birnie et al.   HEART

Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab

(2016) Heleen A. Crommelin et al.   RESPIRATORY MEDICINE

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network

(2016) Hélène Vallet et al.   Arthritis & Rheumatology

Google-driven search for big data in autoimmune geoepidemiology: Analysis of 394,827 patients with systemic autoimmune diseases

(2015) Manuel Ramos-Casals et al.   AUTOIMMUNITY REVIEWS

Genetics of Sarcoidosis

(2015) Tasha E. Fingerlin et al.   CLINICS IN CHEST MEDICINE

Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis

(2015) Adriane D.M. Vorselaars et al.   EUROPEAN RESPIRATORY JOURNAL

Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibody

(2015) J. D. Isaacs et al.   JOURNAL OF INTERNAL MEDICINE

Successful use of rituximab in refractory cardiac sarcoidosis

(2015) Megan L. Krause et al.   RHEUMATOLOGY

Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients

(2015) Leyre Riancho-Zarrabeitia et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches

(2015) Robert P Baughman et al.   Lancet Respiratory Medicine

Clinical phenotypes in sarcoidosis

(2014) Carlos A.C. Pereira et al.   CURRENT OPINION IN PULMONARY MEDICINE

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis

(2014) M. A. Judson et al.   EUROPEAN RESPIRATORY JOURNAL

Rituximab in the treatment of refractory pulmonary sarcoidosis

(2014) N. J. Sweiss et al.   EUROPEAN RESPIRATORY JOURNAL

Negative clinical trials in sarcoidosis: failed therapies or flawed study design?

(2014) D. R. Moller   EUROPEAN RESPIRATORY JOURNAL

Association of the TNF-  G-308A polymorphism with TNF-inhibitor response in sarcoidosis

(2014) P. A. Wijnen et al.   EUROPEAN RESPIRATORY JOURNAL

Sarcoidosis: the links between epidemiology and aetiology

(2014) Simon Dubrey et al.   POSTGRADUATE MEDICAL JOURNAL

Efficacy of mycophenolate mofetil in sarcoidosis

(2014) Nabeel Hamzeh et al.   RESPIRATORY MEDICINE

Medical Therapy of Sarcoidosis

(2014) Elyse Lower et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Is it time for biosimilars in autoimmune diseases?

(2013) Maria-Jose Cuadrado et al.   AUTOIMMUNITY REVIEWS

Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis

(2013) Adriane D.M. Vorselaars et al.   CHEST

Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis

(2013) Johanna P. Cremers et al.   CURRENT OPINION IN PULMONARY MEDICINE

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis

(2013) A. D. M. Vorselaars et al.   EUROPEAN RESPIRATORY JOURNAL

Usefulness of Low-dose Methotrexate Monotherapy for Treating Sarcoidosis

(2013) Takuma Isshiki et al.   INTERNAL MEDICINE

Antinuclear antibodies do not predict anti-infliximab antibody induction in sarcoidosis

(2013) Adriane Dore Marie Vorselaars et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Sarcoidosis

(2013) Dominique Valeyre et al.   LANCET

Unknown

(2013) Lara Heij et al.   MOLECULAR MEDICINE

The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: A retrospective analysis from a randomized clinical trial

(2013) Marc A. Judson et al.   RESPIRATORY MEDICINE

Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy

(2013) Eric Russell et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Current and emerging pharmacological treatments for sarcoidosis: a review

(2013) Marc Judson et al.   Drug Design Development and Therapy

Biologics-induced autoimmune diseases

(2012) Roberto Perez-Alvarez et al.   CURRENT OPINION IN RHEUMATOLOGY

Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: Single-center retrospective study of 9 patients

(2012) Thomas Sené et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis

(2012) Robert J. Pariser et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Topical and systemic medications for the treatment of primary Sjögren's syndrome

(2012) Manuel Ramos-Casals et al.   Nature Reviews Rheumatology

Effect and Safety of Mycophenolate Mofetil in Chronic Pulmonary Sarcoidosis: A Retrospective Study

(2012) Anne-Kathrin Brill et al.   RESPIRATION

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review

(2012) Jose Ramon Maneiro et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Management of Cardiac Sarcoidosis in the United States

(2011) Nabeel Y. Hamzeh et al.   CHEST

Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis

(2011) D. H. Sahoo et al.   EUROPEAN RESPIRATORY JOURNAL

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis

(2011) R. J. Erckens et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Sarcoidosis Diagnosed After September 11, 2001, Among Adults Exposed to the World Trade Center Disaster

(2011) Hannah T. Jordan et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy

(2011) G. Androdias et al.   NEUROLOGY

Long-Term Treatment with Infliximab in Patients with Sarcoidosis

(2011) Katrin E. Hostettler et al.   RESPIRATION

Infliximab no tratamento da sarcoidose - Experiência de um hospital central

(2011) M. Aguiar et al.   Revista Portuguesa de Pneumologia

Pharmacotherapy for pulmonary sarcoidosis: A delphi consensus study

(2010) Amanda C. Schutt et al.   RESPIRATORY MEDICINE

Infliximab et sarcoïdose chronique. L’expérience française à propos de 31 cas

(2010) F. Jounieaux et al.   REVUE DES MALADIES RESPIRATOIRES

The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis

(2010) P. A. Wijnen et al.   TISSUE ANTIGENS

Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases

(2009) M Ramos-Casals et al.   LUPUS

Mycophenolate Mofetil Therapy for Sarcoidosis-Associated Uveitis

(2009) Pooja Bhat et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Clinical outcomes in sarcoidosis after cessation of infliximab treatment

(2009) Efstratios PANSELINAS et al.   RESPIROLOGY

Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial

(2008) M. A. Judson et al.   EUROPEAN RESPIRATORY JOURNAL